Back

Clinical impact of perfusion balloon for ST-segment elevated myocardial infarction: RYUSEI study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Advancements in cardiovascular therapies for ST-elevation myocardial infarction: from molecular insights to clinical applications Revascularisation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Masami Nishino

Osaka Rosai Hospital, Sakai (Japan)

9 More presentations in this session

Presentation thumbnail
Relationship between lipoprotein(a) and endogenous fibrinolytic status in patients with STEMI
Doctor J. Leader (Stevenage, GB)
Abstract Slides Video
Presentation thumbnail
The clinical characteristics and prognosis of patients with acute non-ST-segment elevation myocardial infarction complicated with impaired activity daily living
Professor K. Chen (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
ORBI risk score and inflammatory response in patients with acute ST-elevation myocardial infarction
Doctor J. Kunkel (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Combined activation of complement and coagulation is associated with myocardial injury in ST-elevation myocardial infarction
Mr K. Kluge (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with STEMI: new kids on the block
Doctor G. Civieri (Padova, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Advancements in cardiovascular therapies for ST-elevation myocardial infarction: from molecular insights to clinical applications

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Comparison of two different paclitaxel-coated balloons in small native coronary vessel disease
thumbnail
Congress Presentation
Comparative outcomes of drug-coated balloon angioplasty versus second-generation drug-eluting stent for in-stent restenosis: a real-world data analysis
thumbnail
Congress Presentation
Safety and feasibility of drug eluting and perfusion therapy for left main disease: JDEPTH-LM pilot study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources